Parallax Volatility Advisers L.P. bought a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 50,400 shares of the company’s stock, valued at approximately $929,000.
Several other large investors also recently modified their holdings of TDACU. Tuttle Capital Management LLC bought a new stake in Translational Development Acquisition during the fourth quarter worth about $461,000. Wealthspring Capital LLC acquired a new position in shares of Translational Development Acquisition in the 4th quarter valued at approximately $1,095,000. Yakira Capital Management Inc. acquired a new position in shares of Translational Development Acquisition in the 4th quarter valued at approximately $1,106,000. Warberg Asset Management LLC bought a new stake in shares of Translational Development Acquisition during the 4th quarter worth approximately $1,373,000. Finally, Radcliffe Capital Management L.P. acquired a new stake in shares of Translational Development Acquisition during the 4th quarter worth approximately $2,204,000.
Translational Development Acquisition Trading Up 0.1 %
Shares of NASDAQ:TDACU opened at $10.20 on Friday. The company has a 50 day moving average price of $10.15. Translational Development Acquisition Corp. has a 1 year low of $10.00 and a 1 year high of $10.30.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- Earnings Per Share Calculator: How to Calculate EPS
- Markets Think Robinhood Earnings Could Send the Stock Up
- Dividend Capture Strategy: What You Need to Know
- Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains?
- What is a Secondary Public Offering? What Investors Need to Know
- AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.